Anterogen.Co.Ltd (065660.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7065660003
Anterogen.Co.Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 6.93 bn KRW | 7.54 bn KRW |
| Gross profit | 2.63 bn KRW | 2.66 bn KRW |
| Operating income | -3.80 bn KRW | -2.43 bn KRW |
| EBIT | -2.03 bn KRW | -2.43 bn KRW |
| Net income | -2.29 bn KRW | -1.37 bn KRW |
| Diluted EPS – continuing operations | -235.61 KRW | -137.30 KRW |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Anterogen.Co.Ltd
Anterogen.Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. The company offers medicines, including Cupistem injection, an adipose stem cell product that is used for the treatment of Crohn's fistula; Queencell, a stromal vascular fraction used for the regeneration of subcutaneous adipose tissue; and Remodulin injection, a medicine for the treatment of pulmonary arterial hypertension. It also provides cosmetics, such as hair care products comprising SCM2 and SCM2-Black; and skin care products, such as Therastem-Derma, Therastem-White Silk, and Therastem-White Glutathione, as well as human stem cell conditioned media, a cosmetic raw material. In addition, the company offers cell banking services; and analysis services that include sample analysis for clinical studies, as well as conducts biopharmaceutical tests for identification, purity, potency, adventitious virus, etc. Anterogen.Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
More stocks
- Niching Industrial (3444.TWO)
- Southern Silver Exploration Corp. (SSV.V)
- T3 Entertainment Inc. (204610.KQ)
- Lin Horn Technology Co Ltd (5464.TWO)
- DeviceENG.CO.Ltd (187870.KQ)
- Zomedica Corp. (ZOMDF)
- CURATIS N AG (CURN.SW)
- Perspective Therapeutics, Inc. (CATX)
- SPSoft Inc. (443670.KQ)
- Shinhung (004080.KS)
- AEWIN Technologies Co.Ltd. (3564.TWO)
- Patria Bank SA (PBK.RO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.